GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a prominent focus in medical research, largely due to its remarkable impact on managing conditions such as adult-onset diabetes and obesity. New research have demonstrated that in addition to glucose regulation, GLP-1 agonists offer promise for heart health and even brain c